Current position: Home >> Scientific Research >> Research Projects

凝血酶受体-1抑制剂1.1类抗血小板重大新药Andropaxpar的临床前研究

Hits:

Project Name:凝血酶受体-1抑制剂1.1类抗血小板重大新药Andropaxpar的临床前研究

Institution:药学院

Leading Scientist:娄红祥

Nature of Project:纵向

Project Level:National

Project Participants:常文强,Han Jenny,张海艇,娄红祥,孙斌,翟光喜,任冬梅,邢杰,王小宁,范培红,沈涛,Shuqi Wang

Project Number:9A6E9BCE7CDA6082E053BE07C2CADA2D

Project Approval Number:2019ZX09301-112

Date of Project Approval:2019-01-01

Scheduled Completion Time:2020-12-31

Date of Project Completion:2020-12-31

Date of Project Initiation:2019-01-01

Release Time:2020-03-22

Prev One:通过上调RND1表达介导EMT抑制的天然产物发现及其抗肿瘤转移作用和机制研究

Next One:诱导细胞巨泡式死亡的异戊烯基取代类化合物的发现及作用机制